TARG1通过调节RNA代谢来影响EGFR信号传递
Mihály Mérey1,2, Roberta Fajka-Boja1,3, Gergely Imre4,5
1Laboratory of DNA Damage and Nuclear Dynamics, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, 6726, Hungary.
Scientific reports
|July 2, 2025
概括
酶TARG1通过影响其mRNA水平和翻译来调节表皮生长因子受体 (EGFR). TARG1 枯竭影响RNA代谢,使细胞对MEK1/2 抑制产生敏感性,这表明它在癌症信号传递中的作用.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 表皮生长因子受体 (EGFR) 信号传递对细胞功能至关重要.
- ADP-ribosylation在EGFR调节中的作用正在出现,其中涉及PARP.
- 与TARG1一样,ADP (基) 水解酶在EGFR信号传递中的作用仍然不清楚.
研究的目的:
- 研究TARG1,一种酶在EGFR信号传递中的作用.
- 确定TARG1耗尽对EGFR表达和RNA代谢的影响.
- 探索TARG1,RNA生物发生和Ras/MEK/ERK通路之间的潜在联系.
主要方法:
- 在U2-OS骨髓瘤细胞中利用TARG1的淘汰 (KO) 和淘汰 (KD) 模型.
- 在TARG1耗尽后评估EGFR蛋白和mRNA水平.
- 分析了mRNA周转,RNA分布和翻译效率.
- 评估细胞对MEK1/2抑制的敏感性.
主要成果:
- 由于TARG1的减少,EGFR蛋白和mRNA水平下降.
- 丢失TARG1导致mRNA循环增加,并改变了RNA的分布和翻译.
- 缺少TARG1的细胞对MEK1/2抑制的敏感性增加.
- 研究结果表明,TARG1影响RNA代谢和转化调节.
结论:
- TARG1调节EGFR的表达和翻译,可能是通过RNA生物发生机制.
- TARG1在RNA代谢和翻译中的作用影响癌细胞信号传递.
- 在TARG1和Ras/MEK/ERK通路之间存在潜在的交叉通路,这与癌症存活相关.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K


